Movement Alert|Synopsys Falls 3.04% in Regular Trading, Kimi K3 Disruption Narrative Continues to Pressure EDA Stocks

Market Focus
Jul 23

On July 23, Synopsys declined 3.04% in regular trading, trading at $377.25/share, with turnover of $314 million, erasing the prior session's 3.14% gain.

On the news front, lingering concerns over China's Kimi K3 AI model — which demonstrated a complete chip design workflow in just 48 hours using open-source EDA tools — continued to weigh on traditional EDA leaders. The market remains cautious about the potential erosion of the commercial monopoly long enjoyed by incumbent EDA vendors. The initial shock from the Kimi K3 announcement on July 18 had already triggered intraday declines exceeding 12% for both Synopsys and Cadence Design Systems.

While Needham reiterated its Buy rating on Synopsys on July 22, arguing that agentic AI will re-accelerate EDA software licensing growth rather than disrupt incumbents, the stock failed to sustain the resulting bounce. The broader backdrop of customer attrition fears — stemming from Synopsys's strategic decision to discontinue its fab process control software suite — has compounded selling pressure in recent sessions.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10